Can risk factor screening predict Hepatitis C antibody reactivity?

American Journal of Perinatology

Volumn 15, Issue 6, 1998, Pages 395-398

  Magriples, Urania ^a,b   Bernstein, Peter ^a   Snyder, Edward ^a   Copel, Joshua A ^a  

^a YALE UNIVERSITY   (United States)

^b YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Hepatitis C; Hepatitis C epidemiology; Hepatitis C screening

Indexed keywords

HEPATITIS C ANTIBODY;

ADULT; ARTICLE; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HEPATITIS C; HUMAN; IMMUNOBLOTTING; INTRAVENOUS DRUG ABUSE; MAJOR CLINICAL STUDY; PREDICTION; PRENATAL CARE; PREVALENCE; PRIORITY JOURNAL; RISK FACTOR; SCREENING;

EID: 0031820759     PISSN: 07351631     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2007-993964     Document Type: Article

References (13)

1. Kuo G, Choo Q-L, Alter HJ, Gitnick GL, Redeker AG, Purcell RH, et al. An assay for circulating antibodies to a major etiologic virus of human non-A, non-B hepatitis. Science 1989;244:362-364
2. Nishioka K, Watanabe J, Furuta S, Tanaka E, Iino S, Suzuki H, et al. A high prevalence of antibodies to the hepatitis C virus in patients with hepatocellular carcinoma in Japan. Cancer 1991;67:429-433
3. Alter HJ. Inapparent transmission of hepatitis C: footprints in the sand. Hepatology 1991;14:389-91
4. Coltorti M, Caporaso N, Morisco F, Suozzo R, Romano M, D'Antonio M. Prevalence of Hepatitis C virus infection in the household contacts of patients with HCV-related chronic liver disease. Infection 1994;22:183-186
5. Daikos GL, Lai S, Fischl MA. Hepatitis C virus infection in a sexually active inner city population. The potential for heterosexual transmission. Infection 1994;22:72-76
6. Eyster ME, Alter HJ, Aledort LA, Goedert JJ Cotransmission of hepatitis C virus virus (HCV) and human immunodefiency virus (HIV) from men with hemophilia to their sexual partners. Blood 1990;76:398a
7. Bohman VR, Stettler W, Little BB, Wendel GD, Sutor LJ, Cunningham FG. Seroprevalence and risk factors for hepatitis C virus antibody in pregnant women. Obstet Gynecol 1992;80:609-613
8. Silverman NS, Jenkin BK, Wu C, McGillen P, Knee G. Hepatitis C virus in pregnancy: Seroprevalence and risk factors for infection. Am J Obstet Gynecol 1993;169:583-587
9. Leikin EL, Reinus JF, Schmell E, Tejani N. Epidemiologic predictors of hepatitis C virus infection in pregnant women. Obstet Gynecol 1994;84:529-534
10. McFarlane IG, Smith HM, Johnson PJ, Bray GP, Vergani D, Williams R. Hepatitis C virus antibodies in chronic active hepatitis: pathogenic factor or false-positive result? Lancet 1990;335:754-757
11. Hensher DA, Johnson LW. Applied discrete-choice modelling. London: Croom Helm LTD, 1981:163-192
12. Beardsley AM, LaBrooy JT, Rozen L, Gowans EJ. A comparison of hepatitis C virus (HCV)-RNA and antibody as markers of infection and predictors of infectivity. Aust N ZJ Med 1994;24:182-187
13. Hino K, Sainokami S, Shimoda K, Niwa H, Iino S. Clinical course of acute hepatitis C and changes in HCV markers. Dig Dis Sci 1994;39:19-27